Chronic Migraine, Headache Clinical Trial
Official title:
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine Prevention in High-Frequency and Chronic Migraine: the Standard Paradigm
This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs/month) requiring preventive treatment. Enrolled patients will receive DAX administered subcutaneously using an established, published, legacy injection paradigm (referred to herein as the "standard paradigm"). The safety and efficacy outcome measures will be assessed at selected dosing segments during the 24-week treatment phase.
Patients enrolled who meet eligibility will receive a total of 310 units of DAXI Injections in divided doses over 31 landmarks (sites), including the face, head, neck and shoulders, as identified per the standard paradigm, at visit 2. Follow-up visits via combination of phone and in office will occur at V3, week 8, through V9, week 24. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04520425 -
Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches
|
N/A | |
| Recruiting |
NCT06247592 -
Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
|
N/A | |
| Recruiting |
NCT04989413 -
Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
|
Phase 4 | |
| Recruiting |
NCT06138171 -
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
|
||
| Active, not recruiting |
NCT06109389 -
The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache
|
Phase 2 | |
| Completed |
NCT04871581 -
Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device
|
N/A | |
| Withdrawn |
NCT01749423 -
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
|
N/A | |
| Terminated |
NCT04349176 -
Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?
|
Phase 3 | |
| Completed |
NCT05381129 -
The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine
|
N/A | |
| Withdrawn |
NCT03465826 -
Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4
|
N/A | |
| Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
| Completed |
NCT03767062 -
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
|
N/A | |
| Completed |
NCT05748535 -
Effect of Auricular Vagus Nerve Stimulation in Women With Migraine Disease
|
N/A | |
| Recruiting |
NCT05724771 -
COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
|
Phase 4 | |
| Recruiting |
NCT05313503 -
KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs
|
N/A | |
| Recruiting |
NCT05079659 -
Rate , Predictors and Outcome of Chronic Migraine
|
||
| Completed |
NCT06118190 -
Mesotherapy in the Treatment of Chronic Migraine
|
N/A | |
| Completed |
NCT03698409 -
Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.
|
Phase 4 | |
| Completed |
NCT04017741 -
A Study Investigating the Efficacy of GON Blocks.
|
Phase 4 | |
| Completed |
NCT05679908 -
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
|
Phase 2 |